NAD(P)H:Quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors

Carcinogenesis

Volumn 21, Issue 10, 2000, Pages 1813-1819

  Lafuente, M J ^a   Casterad, X ^b   Trias, M ^c   Ascaso, C ^d   Molina, R ^d   Ballesta, A ^d   Zheng, S ^e   Wiencke, J K ^e   Lafuente, A ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c University Hospital of St Pau (Cardiology)   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BENZOQUINONE; CARCINOGEN; MUTAGENIC AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CODON; COLORECTAL CANCER; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FEMALE; GENDER; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL ANALYSIS;

EID: 0033782995     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.10.1813     Document Type: Article

References (49)

1. Human colonocyte detoxification
2. DT-diaphorase
3. Contemporary issues in toxicology. Quinone chemistry and toxicity
4. Molecular mechanisms of quinone cytotoxicity
5. Enzyme-directed bioreductive drug development revisited: A commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase
6. Human NAD(P)H quinone oxidoreductase (NQO1) gene structure and induction by dioxin
7. NAD(P)H:Quinone oxidoreductase gene expression in human colon carcinoma cells: Characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity
8. Re: Detection of a point mutation in NQO1 (DT-diaphorase) in a patient with colon cancer
9. Ethnic variation in the prevalence of a common NAD(P)H:Quinone oxidoreductase polymorphism and its implications for anticancer chemotherapy
10. Identification of an NAD(P)H:Quinone oxidoreductase polymorphism and its association with lung cancer and smoking
11. Predisposition towards urolithiasis associated with the NQO1 nullallele
12. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H:quinone oxidoreductase polymorphism
13. Association of the NAD(P)H:Quinone oxidoreductase 609CT polymorphism with a decreased lung cancer risk
14. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C to T mutation and rapid fractional excretion of chlorzoxazone
15. A lack of a functional NAD(P)H:Quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions
16. NAD(P)H:Quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia
17. Association of NAD(P)H:Quinone oxidoreductase (NQO1) with numbers of basal cell carcinomas: Use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci
18. Increased frequency of the null-allele for NAD(P)H:Quinone oxidoreductase in patients with urological malignancies
19. NAD(P)H quinone oxidoreductase 1 (DT-diaphorase) specifically prevents the formation of benzo(a)pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase
20. Modulation of the toxicity and macromolecular binding of benzene metabolites by NAD(P)H:Quinone oxidoreductase in transfected HL-60 cells
21. The potent antioxidant activity of the vitamin K cycle in microsomal lipid peroxidation
22. Antimutagenic effects and possible mechanimsms of action of vitamins and related compounds against genotoxic heterocyclic amines from cooked food
23. The pathway to signal achievement
24. K-ras mutation in colorectal cancer: Relations to patient age, sex and tumour location
25. Characterization of a polymorphism in NAD(P)H:Quinone oxidoreductase (DT-diaphorase)
26. Implications and prognostic value of K-ras mutation in early stage lung cancer in women
27. A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia
28. Colorectal cancer: Molecules and populations
29. 609 C to T polymorphism in NAD(P)H:Quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia
30. Candidate genetic modifers of individual susceptibility to renal cell carcinoma: A study of polymorphic human xenobiotic-metabolizing enzymes
31. Ki-ras mutation modifies the protective effect of dietary monounsaturated fat and calcium on sporadic colorectal cancer
32. Kirsten ras mutations in patients with colorectal cancer: The multicenter 'RASCAL' study
33. Variation in colorectal cancer incidence in the United States by subsite of origin
34. Polycyclic aromatic hydrocarbons: Correlations between DNA adducts and ras oncogene mutations
35. Inefficient in vivo repair of mismatches at an oncogenic hotspot correlated with lack of binding by mismatch repair proteins and with phase of the cell cycle
36. Stereospecific differences in repair by human cell extracts of synthesized oligonulceotides containing trans-opened 7,8,9,10-tetrahydrobenzo(a)pyrene 7,8-diol 9,10-epoxide N2-dG adduct 12 sequence
37. 8-Hydroxyguanine (7,8-dihydro-8-oxoguanine) in hot spots of the c-Ha-ras gene: Effects of sequence contexts on mutation spectra
38. NAD(P)H:Quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones
39. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status
40. Ki-ras mutations in exocrine pancreatic cancer: Association with clinico-pathological characteristics and with tobacco and alcohol consumption
41. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women
42. K-ras mutations in human adenocarcinoma of the lung: Association with smoking and occupational exposure to asbestos
43. Distribution of p53 and K-ras mutations in human lung cancer tissues
44. Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer?
45. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
46. P450 enzymes of estrogen metabolism
47. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides
48. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer
49. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogens